Downregulation of m6A Methyltransferase in the Hippocampus of Tyrobp -/- Mice and Implications for Learning and Memory Deficits
Loss-of-function mutations in the gene that encodes TYRO protein kinase-binding protein ( ) cause Nasu-Hakola disease, a heritable disease resembling Alzheimer's disease (AD). Methylation of N6 methyl-adenosine (m6A) in mRNA plays essential roles in learning and memory. Aberrant m6A methylation...
Saved in:
Published in: | Frontiers in neuroscience Vol. 16; p. 739201 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Research Foundation
21-03-2022
Frontiers Media S.A |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Loss-of-function mutations in the gene that encodes TYRO protein kinase-binding protein (
) cause Nasu-Hakola disease, a heritable disease resembling Alzheimer's disease (AD). Methylation of N6 methyl-adenosine (m6A) in mRNA plays essential roles in learning and memory. Aberrant m6A methylation has been detected in AD patients and animal models. In the present study,
mice showed learning and memory deficits in the Morris water maze, which worsened with age.
mice also showed elevated levels of total tau, Ser202/Thr205-phosphorylated tau and amyloid β in the hippocampus and cerebrocortex, which worsened with aging. The m6A methyltransferase components METTL3, METTL14, and WTAP were downregulated in
mice, while expression of demethylases that remove the m6A modification (e.g., FTO and ALKBH5) were unaltered. Methylated RNA immunoprecipitation sequencing identified 498 m6A peaks that were upregulated in
mice, and 312 m6A peaks that were downregulated. Bioinformatic analysis suggested that most of these m6A peaks occur in sequences near stop codons and 3'-untranslated regions. These findings suggest an association between m6A RNA methylation and pathological TYROBP deficiency. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Manoj Kumar Jaiswal, Icahn School of Medicine at Mount Sinai, United States Reviewed by: Benjamin Wolozin, Boston University, United States; Esko Kankuri, University of Helsinki, Finland; Aaron M. Johnson, University of Colorado, United States; Manoj Kandpal, Northwestern University, United States This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience |
ISSN: | 1662-4548 1662-453X 1662-453X |
DOI: | 10.3389/fnins.2022.739201 |